What is 1mg?
Established in 2015 and headquartered in Haryana, India, 1mg operates as a comprehensive digital consumer healthcare platform. Its services encompass an e-pharmacy, online medical consultations, and laboratory testing, aiming to provide accessible and integrated healthcare solutions. The company's strategic focus on leveraging technology to enhance healthcare delivery positions it as a key player in India's rapidly evolving digital health landscape. Keywords: 1mg, digital healthcare, e-pharmacy, online consultations, India, healthtech, consumer health, pharmaceutical platform, medical technology.
How much funding has 1mg raised?
1mg has raised a total of $158M across 6 funding rounds:
Series A
$6M
Series B
$16M
Other Financing Round
$10M
Series C
$15M
Series D
$70M
Other Financing Round
$41M
Series A (2015): $6M with participation from Intel Capital, Kae Capital, Omidyar Network, and Steamboat Ventures
Series B (2016): $16M led by Maverick Ventures, Omidyar Network, and Seqouia Capital
Other Financing Round (2017): $10M supported by Omidyar Network, HBM Healthcare Investments, and Steamboat Ventures
Series C (2017): $15M featuring Kae Capital, Sequoia India, Omidyar Network, HBM Healthcare Investments, and Maverick Ventures
Series D (2019): $70M backed by Redwood Global, Maverick Ventures, Steamboat Ventures, Korea Omega Healthcare fund, and Corisol Holdings
Other Financing Round (2022): $41M with participation from Tata Group
Key Investors in 1mg
Intel Capital
Intel Capital, a division of Intel, invests in innovative startups across various technology sectors, including AI and cloud computing, and actively facilitates business development introductions.
Sequoia India
Sequoia Capital India invests across venture, growth, and late-stage opportunities in India, acting as an active partner to entrepreneurs and management teams in the technology sector.
Omidyar Network
Omidyar Network is a philanthropy focused on shaping the digital revolution to promote shared power and possibility, engaging with innovators in technology and governance.
What's next for 1mg?
The recent major strategic investment in 1mg signals a robust phase of scaling and potential market expansion. This capital infusion is likely to be directed towards enhancing its technological infrastructure, broadening its service offerings, and potentially exploring new geographical markets. The company's trajectory suggests a move towards solidifying its leadership in the digital health sector, with a focus on innovation and customer-centric solutions. Future growth may involve strategic partnerships and further development of its integrated healthcare ecosystem.
See full 1mg company page
